Bayer Japan Files Additional Indication Of Eylea For Diabetic Macular Edema
This article was originally published in PharmAsia News
Executive Summary
Bayer filed for an additional indication of diabetic macular edema for its VEGF inhibitor Eylea (aflibercept) intravitreal injection in Japan.